HC Wainwright Has Positive Estimate for ALDX Q2 Earnings
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) – Research analysts at HC Wainwright upped their Q2 2025 EPS estimates for shares of Aldeyra Therapeutics in a report released on Monday, May 19th. HC Wainwright analyst M. Caufield now forecasts that the biotechnology company will post earnings per share of ($0.18) for the quarter, up from […]
